Neurocrine Biosciences, Inc. 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-24 06:15 am Purchase |
2023-02-23 | 13D | Voyager Therapeutics, Inc. VYGR |
NEUROCRINE BIOSCIENCES INC NBIX |
8,575,316 19.900% |
4,395,588 (+105.16%) |
Filing |